Nothing seems to bother NASDAQ:FPRX, NASDAQ:KEQU, NYSE:BRT, NASDAQ:XTLB

FIVE PRIME THERAPEUTICS EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:FPRX)

IS FIVE PRIME THERAPEUTICS A BUY RIGHT NOW? (NASDAQ:FPRX)

8 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Five Prime Therapeutics in the last twelve months. There are currently 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” Five Prime Therapeutics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FPRX, but not buy additional shares or sell existing shares.
Five Prime Therapeutics

KEWAUNEE SCIENTIFIC (NASDAQ:KEQU) EARNINGS INFORMATION (NASDAQ:KEQU)

Kewaunee Scientific last posted its quarterly earnings results on December 9th, 2020. The technology company reported ($0.07) EPS for the quarter. The firm earned $39 million during the quarter. Kewaunee Scientific has generated $0.00 earnings per share over the last year. Kewaunee Scientific has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, July 20th, 2021 based off prior year’s report dates.

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN KEWAUNEE SCIENTIFIC? (NASDAQ:KEQU)

Wall Street analysts have given Kewaunee Scientific a “N/A” rating, but there may be better short-term opportunities in the market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Kewaunee Scientific wasn’t one of them. MarketBeat thinks these five stocks may be even better buys.

BRT APARTMENTS (NYSE:BRT) EARNINGS INFORMATION (NYSE:BRT)

BRT Apartments last released its earnings data on March 11th, 2021. The financial services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.07. BRT Apartments has generated $0.00 earnings per share over the last year. BRT Apartments has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, June 16th, 2021 based off prior year’s report dates.

IS BRT APARTMENTS A BUY RIGHT NOW? (NYSE:BRT)

3 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for BRT Apartments in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” BRT Apartments stock.
BRT Apartments

XTL BIOPHARMACEUTICALS EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:XTLB)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN XTL BIOPHARMACEUTICALS? (NASDAQ:XTLB)

Wall Street analysts have given XTL Biopharmaceuticals a “N/A” rating, but there may be better short-term opportunities in the market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but XTL Biopharmaceuticals wasn’t one of them. MarketBeat thinks these five stocks may be even better buys.